What is Qrons Inc?
, through its subsidiaries, engages in the formulation and distribution of wholesale food grade functional mushrooms and cognitive performance products focusing on the mental performance and wellness markets in the United States.
QRON · Verdict
Limited reward · high risk
QRON's standout is volatility; cash flow and balance sheet weigh on the picture.
Based on 88% data coverage
QRON · Verdict
Above average
Weak vs peers
Current ratio 0.00
-5734% return on equity
Earnings -62.5% CAGR
Below average
Model-based scoring. For information only — not financial advice.
, through its subsidiaries, engages in the formulation and distribution of wholesale food grade functional mushrooms and cognitive performance products focusing on the mental performance and wellness markets in the United States. It focuses on the research and development of psilocybin mushrooms. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 199.80K.
The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.